Advertisement

Patient Priorities

  • Fernando MagroEmail author
  • Inês Pita
Chapter

Abstract

Inflammatory bowel disease (IBD) is a systemic disease. Apart from the complexities of managing bowel inflammation per se, it is important to consider the patient as a whole. IBD patients tend to be young and in their working and reproductive years; although it should not be forgotten that a relevant proportion is diagnosed after 60. This chapter explores how active and inactive IBD may cause a significant physical and psychological burden and the importance that health-care professionals understand each patient’s experience and expectations about their disease. This chapter focuses on pain, fatigue and urgency; some of the symptoms that most frequently concern patients on their daily basis. The text explores the possible mechanisms behind them and their differential diagnoses, such as the numerous causes of urgency and diarrhoea in the IBD patient other than active disease. The management of each symptom is also examined, including practical daily tips for altered bowel habit and non-pharmacological therapies for fatigue.

Keywords

Fatigue Abdominal pain Urgency 

References

  1. Artom M, Czuber-Dochan W, Sturt J, Norton C (2016) Targets for health interventions for inflammatory bowel disease-fatigue. J Crohns Colitis 10:860–869CrossRefGoogle Scholar
  2. Banovic I, Gilibert D, Jebrane A, Cosnes J (2012) Personality and fatigue perception in a sample of IBD outpatients in remission: a preliminary study. J Crohns Colitis 6:571–577CrossRefGoogle Scholar
  3. Bernstein CN (2015) Treatment of IBD: where we are and where we are going. Am J Gastroenterol 110:114–126CrossRefGoogle Scholar
  4. Casellas F, Herrera-de Guise C, Robles V, Navarro E, Borruel N (2017) Patient preferences for inflammatory bowel disease treatment objectives. Dig Liver Dis 49:152–156CrossRefGoogle Scholar
  5. Czuber-Dochan W, Ream E, Norton C (2013) Review article: description and management of fatigue in inflammatory bowel disease. Aliment Pharmacol Ther 37:505–516CrossRefGoogle Scholar
  6. de Rooy EC, Toner BB, Maunder RG et al (2001) Concerns of patients with inflammatory bowel disease: results from a clinical population. Am J Gastroenterol 96:1816–1821CrossRefGoogle Scholar
  7. Dibley L, Bager P, Czuber-Dochan W et al (2016) Identification of research priorities for inflammatory bowel disease nursing in Europe: a Nurses-European Crohn’s and colitis organisation Delphi survey. J Crohns Colitis 11(3):353–359Google Scholar
  8. Feldman M, Friedman LS, Brandt LJ (2016) Sleisenger and Fordtran’s gastrointestinal and liver disease: pathophysiology, diagnosis, management, 10th edn. Sanders/Elsevier, PhiladelphiaGoogle Scholar
  9. Ford AC, Talley NJ, Spiegel BM et al (2008) Effect of fibre, antispasmodics, and peppermint oil in the treatment of irritable bowel syndrome: systematic review and meta-analysis. BMJ 337:a2313CrossRefGoogle Scholar
  10. Froslie KF, Jahnsen J, Moum BA, Vatn MH, Group I (2007) Mucosal healing in inflammatory bowel disease: results from a Norwegian population-based cohort. Gastroenterology 133:412–422CrossRefGoogle Scholar
  11. García-Vega E, Fernandez-Rodriguez C (2004) A stress management programme for Crohn’s disease. Behav Res Ther 42:367–383CrossRefGoogle Scholar
  12. Gracie DJ, Ford AC (2017) Letter: causes of fatigue in inflammatory bowel disease remain uncertain. Aliment Pharmacol Ther 45:762–763CrossRefGoogle Scholar
  13. Huppertz-Hauss G, Hoivik ML, Jelsness-Jorgensen LP et al (2017) Fatigue in a population-based cohort of patients with inflammatory bowel disease 20 years after diagnosis: the IBSEN study. Scand J Gastroenterol 52:351–358CrossRefGoogle Scholar
  14. Jelsness-Jorgensen LP, Bernklev T, Henriksen M, Torp R, Moum BA (2011) Chronic fatigue is more prevalent in patients with inflammatory bowel disease than in healthy controls. Inflamm Bowel Dis 17:1564–1572CrossRefGoogle Scholar
  15. Keohane J, O’Mahony C, O’Mahony L, O’Mahony S, Quigley EM, Shanahan F (2010) Irritable bowel syndrome-type symptoms in patients with inflammatory bowel disease: a real association or reflection of occult inflammation? Am J Gastroenterol 105(1788):9–94; quiz 95Google Scholar
  16. Kreijne JE, Lie MR, Vogelaar L, van der Woude CJ (2016) Practical guideline for fatigue management in inflammatory bowel disease. J Crohns Colitis 10:105–111CrossRefGoogle Scholar
  17. Lichtenstein GR, Bala M, Han C, DeWoody K, Schaible T (2002) Infliximab improves quality of life in patients with Crohn’s disease. Inflamm Bowel Dis 8:237–243CrossRefGoogle Scholar
  18. Loftus EV, Feagan BG, Colombel JF et al (2008) Effects of adalimumab maintenance therapy on health-related quality of life of patients with Crohn’s disease: patient-reported outcomes of the CHARM trial. Am J Gastroenterol 103:3132–3141CrossRefGoogle Scholar
  19. Mason I (2007) Continence care for patients with inflammatory bowel disease. Nurs Stand 22:43–46CrossRefGoogle Scholar
  20. McNelly AS, Monti M, Grimble GK et al (2016) The effect of increasing physical activity and/or omega-3 supplementation on fatigue in inflammatory bowel disease. Gastrointest Nurs 14:39–50CrossRefGoogle Scholar
  21. Minderhoud I (2003) High prevalence of fatigue in quiescent inflammatory bowel disease is not related to adrenocortical insufficiency. Am J Gastroenterol 98:1088–1093CrossRefGoogle Scholar
  22. Opheim R, Fagermoen MS, Jelsness-Jorgensen LP, Bernklev T, Moum B (2014) Sense of coherence in patients with inflammatory bowel disease. Gastroenterol Res Pract 2014:989038CrossRefGoogle Scholar
  23. Romberg-Camps MJ, Bol Y, Dagnelie PC et al (2010) Fatigue and health-related quality of life in inflammatory bowel disease: results from a population-based study in the Netherlands: the IBD-South Limburg cohort. Inflamm Bowel Dis 16:2137–2147CrossRefGoogle Scholar
  24. Schirbel A (2010) Impact of pain on health-related quality of life in patients with inflammatory bowel disease. World J Gastroenterol 16:3168CrossRefGoogle Scholar
  25. Sharpe M, Wilks D (2002) Fatigue. BMJ 325:480–483CrossRefGoogle Scholar
  26. Singh S, Graff LA, Bernstein CN (2009) Do NSAIDs, antibiotics, infections, or stress trigger flares in IBD? Am J Gastroenterol 104:1298–1313; quiz 314CrossRefGoogle Scholar
  27. Srinath AI, Walter C, Newara MC, Szigethy EM (2012) Pain management in patients with inflammatory bowel disease: insights for the clinician. Ther Adv Gastroenterol 5:339–357CrossRefGoogle Scholar
  28. Swain MG (2000) Fatigue in chronic disease. Clin Sci (Lond) 99:1–8CrossRefGoogle Scholar
  29. van Langenberg DR, Gibson PR (2014) Factors associated with physical and cognitive fatigue in patients with Crohn’s disease: a cross-sectional and longitudinal study. Inflamm Bowel Dis 20:115–125CrossRefGoogle Scholar
  30. Vogelaar L, van’t Spijker A, Timman R et al (2014) Fatigue management in patients with IBD: a randomised controlled trial. Gut 63:911–918CrossRefGoogle Scholar
  31. Wenzl HH (2012) Diarrhea in chronic inflammatory bowel diseases. Gastroenterol Clin N Am 41:651–675CrossRefGoogle Scholar
  32. Williet N, Sandborn WJ, Peyrin-Biroulet L (2014) Patient-reported outcomes as primary end points in clinical trials of inflammatory bowel disease. Clin Gastroenterol Hepatol 12:1246–1256 e6CrossRefGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2019

Authors and Affiliations

  1. 1.Department of Biomedicine, Unit of Pharmacology and Therapeutics, Faculty of MedicineUniversity of PortoPortoPortugal
  2. 2.MedInUP, Centre for Drug Discovery and Innovative MedicinesUniversity of PortoPortoPortugal
  3. 3.Gastroenterology DepartmentCentro Hospitalar de São JoãoPortoPortugal
  4. 4.Gastroenterology DepartmentInstituto Português de Oncologia do Porto de Francisco GentilPortoPortugal

Personalised recommendations